After several months of inactivity in the realm of digital health IPOs, significant changes are on the horizon. The virtual physical therapy company Hinge Health has recently taken a pivotal step by filing an S-1 registration statement last month. In an insightful discussion, MedCity News Editor-in-Chief Arundhati Parmar and Samir Batra, managing partner of Health Innovation Pitch (HIP), explored key aspects of this S-1 filing. They debated whether Hinge Health can successfully broaden its customer base beyond just self-insured employers. Furthermore, they examined how the unpredictable nature of the current market could impact the company’s debut on the New York Stock Exchange, which is crucial for its future growth and investor confidence.
The recent decision by 23andMe to file for bankruptcy, alongside the resignation of its CEO, signifies a notable shift in the landscape of direct-to-consumer DNA testing and analysis. This event has prompted discussions about the challenges faced by companies in this sector. On the Debunked Podcast, experts deliberated on how a particular payer’s decision to withhold critical data has significantly compromised the integrity and usefulness of a recent healthcare study conducted in New York, highlighting the complexities of data sharing in the industry.
For those seeking to stay updated on the latest developments in litigation, regulation, deals, and trends in financial services, we highly recommend subscribing to Finance Docket. This newsletter is a collaborative effort between Breaking Media publications, including Above the Law and Dealbreaker, ensuring you receive comprehensive insights and analysis.
